Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; monobasic sodium phosphate; octoxinol 9; dibasic sodium phosphate - fluquadri is indicated for active immunisation of influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine.,fluquadri is indicated for use in adults and children 6 months and older.

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine distemper virus - living; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvo virus - misc. vaccines or anti sera - canine distemper virus - living vaccine-viral active 0.0 undefined; canine parainfluenza virus vaccine-viral active 0.0 undefined; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 undefined; canine parvo virus vaccine-viral active 0.0 undefined - immunotherapy - dog | bitch | castrate | puppy - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | vaccine | equine rotavirus | parvovirus

Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human - vaccines - active immunisation against h5n1 subtype of influenza a virus.; this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain.; prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human, immunization, disease outbreaks - vaccines, - active immunisation against h5n1 subtype of influenza a virus., this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain., prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.,

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - bordetella bronchiseptica; canine parainfluenza virus; aluminium hydroxide - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 0.05 ug/ml; canine parainfluenza virus vaccine-viral active 1000000.0 tci50/ml; aluminium hydroxide mineral-aluminium-base other 3.0 mg/ml - immunotherapy - dog - with exclusions see label - bordetella spp. | canine parainfluenza | bordetella bronchiseptica

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - living canine parainfluenza virus - misc. vaccines or anti sera - living canine parainfluenza virus vaccine-viral active 0.0 tcid50 - immunotherapy - dog | bitch | castrate | puppy - respiratory disease

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - influenza virus, quantity: 10000000 ffu - spray, nasal - excipient ingredients: arginine hydrochloride; monosodium glutamate monohydrate; sucrose; monobasic potassium phosphate; gelatin; dibasic potassium phosphate; water for injections - flumist quadrivalent is indicated for the prevention of influenza in children and adolescents from 24 months to less than 18 years of age.

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine distemper virus - living; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvo virus type 2 - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 qs dose; canine distemper virus - living vaccine-viral active 0.0 qs dose; canine parainfluenza virus vaccine-viral active 0.0 qs dose; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 qs dose; canine parvo virus type 2 vaccine-viral active 0.0 qs dose - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parvovirus | hepatitis :- infectious | parainfluenza virus type 2 (infections) | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infections caused by parainflu | infectious canine hepatitis | infectious tracheobronchitis | parvovirus

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parainfluenza type 2; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parainfluenza type 2 vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | parvovirus

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - canine adeno virus type 2; canine distemper virus - living; canine parainfluenza virus; canine parvo virus type 2 - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 u; canine distemper virus - living vaccine-viral active 0.0 u; canine parainfluenza virus vaccine-viral active 0.0 u; canine parvo virus type 2 vaccine-viral active 0.0 u - immunotherapy - dog | bitch | castrate | puppy - canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus